Verrica Pharmaceuticals Inc.
Last verified 2026-05-07. JSON
| Total raised | $50.0M |
|---|---|
| Latest round | Funding round, $50.0M, 2025-12-10 |
| Founded | unknown |
| Headquarters | WEST CHESTER, PA |
| Industry | bio |
| Stage | unknown |
| Website | verricapharmaceuticals.com |
Verrica Pharmaceuticals is a dermatology company that develops and commercializes medical treatments for skin diseases. It serves dermatologists and patients, with a focus on conditions such as molluscum contagiosum and common warts. Its lead therapy is delivered through a proprietary single-use applicator designed for precise, controlled topical administration in the clinic.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-12-10 | Funding round | $50.0M | undisclosed |
Detected tech stack
Cloudflare, WordPress, AitThemes, Google Tag Manager, Font Awesome, jQuery Migrate 3.4.1, Elementor 3.19.2, Plesk, Python, PHP, MySQL, jquery 3.
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $50.0M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Total raised $50.0M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Company existence | self-reported | verricapharmaceuticals.com, read 2026-05-07 |
| Description | self-reported | verricapharmaceuticals.com, read 2026-05-07 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $50.0M, 2025-12-10 → Funding round, $50.0M, 2025-12-10, SEC EDGAR, document, retrieved 2026-09-25 | Latest round | seed, $50.0M, 2025-12-10 → Funding round, $50.0M, 2025-12-10 | SEC EDGAR, document, retrieved 2026-09-25 |
| 2026-09-25Round: attributed → sourced, SEC EDGAR, document, retrieved 2026-09-25 | Round | attributed → sourced | SEC EDGAR, document, retrieved 2026-09-25 |
Records begin 2026-09-24. All changes